MENU
ESLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Estrella Immunopharma (ESLA) Ownership - Who owns Estrella Immunopharma?
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors... Show more
Profile
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 318-9098
Employees
N/A
Web
https://www.estrellabio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.49M
P/E Ratio
N/A
Total Cash
1.8M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ESLA
Capitalization
27.5M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.8M
Total Cash/Share
0.05
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
746K
P/B Ratio
204.08
Cash Flow
N/A
Earnings
-0.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.66K
Current Ratio
0.75
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-56.73
Shares Held By Institutions
509K
Shares Outstanding - Current
36.2M
Total Liabilities
2.99M
Total Volume MTD
N/A
Value
-1
Gain YTD
-36.667
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 318-9098
Employees
N/A
Web
https://www.estrellabio.com